F. Tarragano

Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study).

M. Dalby, J. Dubois-Randé, G. Montalescot, 2003, The American journal of cardiology.

Percutaneous coronary interventions with the Absorb Bioresorbable vascular scaffold in real life: 1-year results from the FRANCE ABSORB registry.

J. Fajadet, H. le Breton, G. Cayla, 2019, Archives of cardiovascular diseases.

[Coronary spastic angina refractory to optimal medical therapy treated by angioplasty and stenting. A case report and review of literature].

P. Henry, P. Beaufils, N. Hajlaoui, 2010, Annales de cardiologie et d'angeiologie.

Three‐year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry

J. Fajadet, H. le Breton, B. Chevalier, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Procedural characteristics of primary coronary angioplasty in diabetic patients with acute anterior myocardial infarction.

P. Henry, L. Bonnevie, P. Beaufils, 2002, Diabetes & metabolism.

Five-year clinical outcomes using the bioresorbable vascular scaffold: Insights from the FRANCE ABSORB registry.

J. Fajadet, H. le Breton, T. Lhermusier, 2022, Archives of cardiovascular diseases.

[Rotational coronary angiography].

P. Henry, G. Sideris, D. Logeart, 2007, Archives des maladies du coeur et des vaisseaux.